Therapeutic taping in patients with diabetic peripheral neuropathy

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2023/01/049324
• Lead Sponsor: KANIKA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Referred cases of Type 1 & Type 2 diabetes mellitus induced diabetic

peripheral neuropathy of lower limbs diagnosed by physician and score more than 2/13 on MNSI physical appearance section and scored greater than 1/10 on physical examination of Michigan neuropathy screening instrument (MNSI)

2. Diabetes duration: >=5 years

3. Age between 40 to 70 years

4.Chronic symmetric sensorimotor involvement of bilateral lower limb

after excluding all other causes of peripheral neuropathies

5. Leeds Assessment of Neuropathic Symptoms Scale (LANSS) score > 12

6.Berg Balance Scale (BBS) <45

7. HbA1C report >=6% not older than 3 months

8. Willing to participate

9. BMI <30kg/m2 (According to Asian criterion)

Exclusion Criteria

1. Allergic to tape

2. Any other diagnosed neuromuscular disease

3. Vestibular system dysfunction in the last one year (complaint of dizziness, vertigo, nausea and loss of balance)

4.Diabetic foot ulcers, neuropathic joint, charcot joint

5. . History of any recent injury (soft tissue and bony) in lower limb six months prior to participation in study

6. Patients with rheumatoid arthritis

7. Patients with varicose veins

8. Any other cause of balance and gait disturbance

9. Deformities of lower limb

10. Patients with leg length discrepancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified